Compounds > ondansetron
Page last updated: 2024-11-01

ondansetron and Bile Duct Obstruction, Intrahepatic

ondansetron has been researched along with Bile Duct Obstruction, Intrahepatic in 2 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schumann, R1
Hudcova, J1
Schwörer, H1
Ramadori, G1

Reviews

1 review available for ondansetron and Bile Duct Obstruction, Intrahepatic

ArticleYear
[Cholestatic pruritus--pathophysiology and therapy with special reference to treatment with 5-hydroxytryptamine subtype 3 receptor antagonists].
    Zeitschrift fur Gastroenterologie, 1995, Volume: 33, Issue:5

    Topics: Adult; Child; Cholestasis, Intrahepatic; Female; Humans; Indoles; Male; Nociceptors; Ondansetron; Pr

1995

Other Studies

1 other study available for ondansetron and Bile Duct Obstruction, Intrahepatic

ArticleYear
Cholestasis of pregnancy, pruritus and 5-hydroxytryptamine 3 receptor antagonists.
    Acta obstetricia et gynecologica Scandinavica, 2004, Volume: 83, Issue:9

    Topics: Cesarean Section; Cholestasis, Intrahepatic; Dose-Response Relationship, Drug; Female; Follow-Up Stu

2004